Detalhe da pesquisa
1.
Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
J Infect Dis
; 205(5): 772-81, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22275401
2.
Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial.
Lancet Infect Dis
; 14(10): 939-46, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25151225
3.
Roles for Treg expansion and HMGB1 signaling through the TLR1-2-6 axis in determining the magnitude of the antigen-specific immune response to MVA85A.
PLoS One
; 8(7): e67922, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23844129
4.
Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
Vaccine
; 31(7): 1026-33, 2013 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23266342
5.
Determining the validity of hospital laboratory reference intervals for healthy young adults participating in early clinical trials of candidate vaccines.
Hum Vaccin Immunother
; 9(8): 1741-51, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23733037
6.
Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial.
Hum Vaccin Immunother
; 9(1): 50-62, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23143773
7.
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation.
Nat Commun
; 4: 2836, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24284865
8.
Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
Vaccine
; 30(38): 5616-24, 2012 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-22789508
9.
Incidental diagnosis in healthy clinical trial subjects.
Clin Transl Sci
; 5(4): 348-50, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22883613
10.
Tuberculosis vaccines in clinical trials.
Expert Rev Vaccines
; 10(5): 645-58, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21604985
11.
A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine.
Vaccine
; 29(43): 7514-22, 2011 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-21501642
12.
A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults.
BMJ Open
; 1(2): e000223, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22102640
13.
Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A.
Clin Vaccine Immunol
; 17(7): 1066-73, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20484570